From pin-pointed cancer treatments using microscopic nanobots to gene editing and cell reprogramming, we are about to witness the transformation of the health and pharmaceutical industry.
The inefficient drug discovery process of the past is about to be revolutionized. It currently costs more than $2.5 billion (sometimes up to $12 billion) and takes over 10 years to bring a new drug to market. Nine out of ten drugs entering Phase I clinical trials will never reach patients.
As the population ages, we don’t have time to rely on this slow, costly production rate. Some 12 percent of the world population will be 65 or older by 2030, and “diseases of aging” like Alzheimer’s will pose increasingly greater challenges to society.
Fueled by massive datasets, skyrocketing computational power, quantum computing, blockchain-enabled patient access, cognitive surplus capabilities and remarkable innovations in AI, the future of human health and longevity is truly worth getting excited about.